Board of Directors

The CMPI Board of Directors is comprised of some of the nation’s leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future.

Peter J. Pitts
President,
Center for Medicine in the Public Interest

Robert M. Goldberg
Vice President & Director of Programs,
Center for Medicine in the Public Interest

Steven Sammut
Lecturer,
Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania

Mark Thornton, M.D., Ph.D.
Chairman and President,
Sarcoma Foundation of America

Michael Weber, M.D.
Professor of Medicine,
SUNY Downstate College of Medicine
Brooklyn, New York
Sign Up for Our Email Newsletter

RECENT NEWS

Richard Bagger Joins CMPI Board of Directors
  • CMPI
  • 09/05/2023 12:00 AM

Richard Bagger Joins CMPI Board of Directors

Richard Bagger, a well-known and respected expert in healthcare and biopharmaceutical policy, has joined the Center for M...  Read more

Reality-Based Healthcare Reform

Reality-Based Healthcare Reform

When it comes to innovation in the development of new medicines, a key focus is on “Real World Evidence,” or data based o...  Read more

Inflation Reduction Act’s Medicare drug price negotiation program is unconstitutional

Inflation Reduction Act’s Medicare drug price negotiation program is unconstitutional

Protecting American health care with true grit...  Read more

DRUGWONKS BLOG